News from ESC 2024: OAC during TAVI

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Comments

Overview
ESC 2024 - In the POPular PAUSE TAVI trial, continuation of oral anticoagulation was not non-inferior to interruption of oral anticoagulation in patients undergoing TAVI.
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Dirk Jan van Ginkel is a physician-researcher at St. Antonius Hospital in Nieuwegein, The Netherlands.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of POPular PAUSE TAVI
Release date: 18 September 2024

Recommended

Details

Presenters

Comments

Overview
ESC 2024 - In the POPular PAUSE TAVI trial, continuation of oral anticoagulation was not non-inferior to interruption of oral anticoagulation in patients undergoing TAVI.
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Dirk Jan van Ginkel is a physician-researcher at St. Antonius Hospital in Nieuwegein, The Netherlands.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of POPular PAUSE TAVI
Release date: 18 September 2024

Continuation or interruption of OAC during TAVI?